Kidney Comics: T-Cell Mediated Rejection (Kidney Transplant)
By: Dr. Momen Abbasi
By: Dr. Momen Abbasi
Please see below re: available medical student/resident travel grants to attend the American Transplant Congress (up to $1000) June 1-5 in Philadelphia, PA. The deadline is March 11th. The application can be submitted here. “The American Transplant Congress (ATC) is the…
Antiretroviral therapy has had a significant impact on improving the survival of patients infected with human immunodeficiency virus (HIV) with their survival now being similar to patients not infected with HIV. With improved long-term survival, the prevalence of…
Introduction Kidney transplantation (KT) has been proven to be the optimal form of kidney replacement therapy (KRT) with resultant lower morbidity and mortality rates, and better quality of life. Why do preemptive kidney transplant recipients have a survival…
Despite tremendous advancements in transplant and immunosuppressive therapy, transplantation in sensitized patients remains a major challenge. The presence of pre-transplant donor-specific antibodies (DSA) is strongly associated with poor outcomes, hyperacute, and antibody-mediated rejection. Sensitization can occur through blood…
121,678 patients in the United States are waiting for organ transplants. Of those patients, 100,791 are in need of a kidney. In 2014 alone, 17,107 patients received a kidney transplant, 11,570 from deceased donors, and 5,537 from living…
Presently, death with a functioning graft is one of the most important causes of kidney transplant failure with the leading cause of death being from cardiovascular events. Withdrawing or avoiding steroids to improve cardiovascular outcomes is a controversial…
Nice debate on ASN Transplant Community about the use of IVIG for BK nephropathy. Personally, I have used IVIG in a handful of patients with refractory BK nephropathy in the past. However, I have convinced myself that there…
The recently published paper in the NEJM entitled “Survival Benefit with Kidney Transplants from HLA-Incompatible LiveDonors” caused a huge impact on Brazil’s media. Our main broadcast TV devoted few minutes explaining it, suggesting as a real breakthrough. Patients…
#NephMadness season is here! The #TransplantRegion has very interesting matchups, but one player that was left out of this contest because is relatively new in the game and relatively unknown, is Mesenchymal Stem Cells (MSCs). In the last few years…